HIGHLIGHTS
- who: Pierre Boulard and collaborators from the Facultu00e9 de Mu00e9decine, Universitu00e9 de Tours, Tours, France have published the paper: Finding the Right Heavy Chains forImmunostimulatory Antibodies, in the Journal: (JOURNAL)
- what: This approach has been mainly developed by targeting members of the TNF-u03b1 receptor family.
SUMMARY
The Perimeter of Immunostimulatory Antibodies The scientific breakthrough and incredible medical success of antibodies targeting immune checkpoints in oncology add to the many other successes of anti-cancer antibodies, i.e., cytotoxic antitumor antibodies, anti-proliferative antibodies, anti-angiogenic antibodies, antibody-drug conjugates, bispecific . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.